Spontaneous metastasis in matrix metalloproteinase 3-deficient mice

Molecular Carcinogenesis

Volumn 48, Issue 7, 2009, Pages 618-625

  Juncker Jensen, Anna ^a   Rømer, John ^a   Pennington, Caroline J ^b   Lund, Leif R ^a   Almholt, Kasper ^a  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Breast cancer; Matrix metalloproteinase; Metastasis; Mouse model; Proteolysis

Indexed keywords

GELATINASE A; GELATINASE B; STROMELYSIN; MESSENGER RNA; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER MODEL; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; ANIMAL; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; GENETICS; HYDROLYSIS; METABOLISM; METASTASIS; PATHOLOGY; POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; FEMALE; HYDROLYSIS; MALE; MATRIX METALLOPROTEINASE 3; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 67649218818     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20503     Document Type: Article

References (63)

1. Jodele S, Blavier L, Yoon JM, DeClerck YA. Modifying the soil to affect the seed: Role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 2006;25:35-43. (Pubitemid 43723980)
2. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516. (Pubitemid 33096184)
3. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-174. (Pubitemid 37328786)
4. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 2000;18:1135-1149. (Pubitemid 30123793)
5. Zhou Z, Apte SS, Soininen R, et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 2000;97:4052-4057. (Pubitemid 30226085)
6. Wylie S, MacDonald IC, Varghese HJ, et al. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells. Clin Exp Metastasis 1999;17:111-117. (Pubitemid 29335436)
7. Kim J, Yu W, Kovalski K, Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 1998;94:353-362. (Pubitemid 28376079)
8. Deryugina EI, Zijlstra A, Partridge JJ, et al. Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. Cancer Res 2005;65:10959-10969. (Pubitemid 41713365)
9. Acuff HB, Carter KJ, Fingleton B, Gorden DL, Matrisian LM. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res 2006;66:259-266. (Pubitemid 43166032)
10. Almholt K, Juncker-Jensen A, Lærum OD, et al. Metastasis is strongly reduced by the matrix metalloprotease inhibitor Galardin in the MMTV-PymTtransgenic breast cancer model. Mol Cancer Ther 2008;9:2758-2767.
11. Bonfil RD, Sabbota A, Nabha S, et al. Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor. Int J Cancer 2006;118:2721-2726. (Pubitemid 43673349)
12. Itoh T, Tanioka M, Matsuda H, et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 1999;17:177-181. (Pubitemid 29335445)
13. Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997;17:439-444. (Pubitemid 27518393)
14. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-13076. (Pubitemid 129518506)
15. Saito S, Katoh M, Masumoto M, Matsumoto S, Masuho Y. Collagen degradation induced by the combination of IL-1alpha and plasminogen in rabbit articular cartilage explant culture. J Biochem (Tokyo) 1997;122:49-54. (Pubitemid 27346221)
16. Abraham D, Ponticos M, Nagase H. Connective tissue remodeling: Cross-talk between endothelins and matrix metalloproteinases. Curr Vasc Pharmacol 2005;3:369-379. (Pubitemid 41264290)
17. Alexander CM, Howard EW, Bissell MJ, Werb Z. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol 1996;135:1669-1677. (Pubitemid 26427660)
18. Knauper V, Wilhelm SM, Seperack PK, et al. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 1993;95:581-586. (Pubitemid 23315202)
19. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;71:1544-1550.
20. Imai K, Yokohama Y, Nakanishi I, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995;70:6691-6697.
21. Benbow U, Schoenermark MP, Mitchell TI, et al. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem 1999;74:25371-25378. (Pubitemid 129531064)
22. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999;74:13066-13076. (Pubitemid 129518506)
23. Cauwe B, Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007;42:113-185. (Pubitemid 46911962)
24. Folgueras AR, Pendas AM,Sanchez LM, Lopez-Otin C. Matrix metalloproteinases in cancer: From new functions to improved inhibition strategies. Int J Dev Biol 2004;48:411-424. (Pubitemid 39360392)
25. McCawley LJ, Matrisian LM. Matrix metalloproteinases: They're not just for matrix anymore. Curr Opin Cell Biol 2001;13:534-540. (Pubitemid 32817010)
26. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007;8:221-233. (Pubitemid 46310551)
27. Wiseman BS, Sternlicht MD, Lund LR, et al. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 2003;162:1123-1133. (Pubitemid 37174194)
28. Lund LR, Romer J, Thomasset N, et al. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways. Development 1996;122:181-193. (Pubitemid 26038430)
29. Talhouk RS, Bissell MJ, Werb Z. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 1992;118:1271-1282.
30. Lund LR, Romer J, Bugge TH, et al. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 1999;18:4645-4656. (Pubitemid 29415519)
31. Johnsen M, Lund LR, Romer J, Almholt K, Dano K. Cancer invasion and tissue remodeling: Common themes in proteolytic matrix degradation. Curr Opin Cell Biol 1998;10:667-671. (Pubitemid 28477027)
32. Martin MD, Matrisian LM. The other side of MMPs: Protective roles in tumor progression. Cancer Metastasis Rev 2007;26:717-724. (Pubitemid 350115119)
33. Witty JP, Lempka T, Coffey RJ Jr, Matrisian LM. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res 1995;55:1401-1406.
34. McCawley LJ, Crawford HC, King LE Jr, Mudgett J, Matrisian LM. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res 2004;64:6965-6972. (Pubitemid 39331006)
35. Sternlicht MD, Lochter A, Sympson CJ, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-146. (Pubitemid 29344902)
36. Sternlicht MD, Bissell MJ, Werb Z. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 2000;19:1102-1113. (Pubitemid 30153797)
37. Van Themsche C, Potworowski EF, St Pierre Y. Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo. Biochem Biophys Res Commun 2004;315:884-891. (Pubitemid 38249386)
38. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 1992;12:954-961.
39. Pedersen TX, Pennington CJ, Almholt K, et al. Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. Carcinogenesis 2005;26:1233-1240. (Pubitemid 41417900)
40. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996;149:273-282. (Pubitemid 26230998)
41. Nakopoulou L, Giannopoulou I, Gakiopoulou H, Liapis H, Tzonou A, Davaris PS. Matrix metalloproteinase-1 and -3 in breast cancer: Correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 1999;30:436-442. (Pubitemid 29177824)
42. Mudgett JS, Hutchinson NI, Chartrain NA, et al. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 1998;41:110-121. (Pubitemid 28041929)
43. Almholt K, Lund LR, Rygaard J, et al. Reduced metastasis of transgenicmammary cancer in urokinase-deficient mice. Int J Cancer 2005;113:525-532. (Pubitemid 40038727)
44. Bugge TH, Lund LR, Kombrinck KK, et al. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene 1998;16:3097-3104. (Pubitemid 28318780)
45. Nielsen BS, Lund LR, Christensen IJ, et al. A precise and efficient stereological method for determining murine lung metastasis volumes. Am J Pathol 2001;158:1997-2003. (Pubitemid 32545185)
46. Price JS, Waters JG, Darrah C, et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 2002;1:57-65.
47. Wells JE, Rice TK, Nuttall RK, et al. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci 2003;23:10107-10115. (Pubitemid 37392558)
48. Maglione JE, Moghanaki D, Young LJ, et al. Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001;61:8298-8305. (Pubitemid 33091625)
49. Herschkowitz JI, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007;8:R76. (Pubitemid 351902765)
50. Lin EY, Jones JG, Li P, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003;163:2113-2126. (Pubitemid 37310040)
51. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996;149:273-282. (Pubitemid 26230998)
52. Nielsen BS, Egeblad M, Rank F, et al. Matrix metalloproteinase 13 is induced in myofibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression. PLoS ONE 2008;8:e2959.
53. Masson V, de la Ballina LR, Munaut C, et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 2005;19:234-236. (Pubitemid 40189266)
54. Stickens D, Behonick DJ, Ortega N, et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 2004;131:5883-5895. (Pubitemid 40123905)
55. Oh J, Takahashi R, Adachi E, et al. Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 2004;23:5041-5048. (Pubitemid 38938737)
56. Solberg H, Rinkenberger J, Dano K, Werb Z, Lund LR. A functional overlap of plasminogen and MMPs regulates vascularization during placental development. Development 2003;130:4439-4450. (Pubitemid 37185331)
57. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 2002;295:2387-2392. (Pubitemid 34270240)
58. Overall CM, Kleifeld O. Tumour microenvironment - opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006;6:227-239.
59. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-744. (Pubitemid 30768157)
60. Agarwal D, Goodison S, Nicholson B, Tarin D, Urquidi V. Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model. Differentiation 2003;71:114-125. (Pubitemid 36359680)
61. Gutiérrez-Fernández A, Fueyo A, Folgueras AR, et al. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res 2008;15:2755-2763. (Pubitemid 351556273)
62. Montel V, Kleeman J, Agarwal D, Spinella D, Kawai K, Tarin D. Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res 2004;64:1687-1694. (Pubitemid 38428690)
63. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9-34.